节点文献

单次注射比阿培南在健康人体的药代动力学

Pharmacokinetics of biapenem injection after single dose administration in healthy volunteers

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 朱燕肖永红吕媛魏敏吉张朴康子胜刘燕梁军张薇张曼李天云

【Author】 ZHU Yan,XIAO Yong-hong, LV Yuan,WEI Min-ji, ZHANG Pu,KANG Zi-sheng, LIU Yan,LIANG JUN, ZHANG Wei,ZHANG Man, LI Tian-yun (Institute of Clinical Pharmacology,Peking University First Hospital,Beijing 100034,China)

【机构】 北京大学第一医院临床药理研究所

【摘要】 目的研究注射用比阿培南(碳青霉烯类抗生素)在健康人群单次给药药代动力学。方法用分层随机、三交叉、拉丁方设计、空腹给药的试验方法,12名健康受试者单次静脉滴注比阿培南150,300,600 mg,HPLC法测定给药后血、尿药物浓度,DAS软件计算药代动力学参数。结果受试者静滴比阿培南150,300,600 mg后药代动力学参数如下,Cmax分别是(8.49±1.03),(16.31±1.83),(34.51±3.74)mg.L-1;Tmax均为(1.00±0.00)h;t1/2β分别为(1.08±0.80),(0.89±0.14),(0.93±0.08)h;AUC0-t分别(13.49±2.29),(28.91±4.92),(60.85±8.72)mg.L-1.h;CL分别是(11.09±1.58),(10.54±1.85),(9.98±1.39)L.h-1.kg-1。12 h尿排出率分别为61.9%,62.1%,62.8%。结论注射用比阿培南药代动力学符合二室开放模型,药代动力学参数与剂量呈线性相关,受试者耐受性良好。

【Abstract】 Objective To study the pharmacokinetic of biapenem injection in healthy volunteers and provide reference for clinical application.Methods Twelve healthy volunteers were enrolled and a single dose of 150,300,600 mg of biapenem was administered intravenously in Latin square design.The drug concentrations of biapenem in plasma and in urine were determined by HPLC method.Pharmacokinetic parameters of biapenem were generated with DAS software.Results The plasma concentration-time curves of biapenem conformed to a 2-compartment pharmarcokinetic model.The main pharmacokinetics parameters of three different dosages(150,300,600 mg) were as follows:Cmax were(8.49±1.03),(16.31±1.83),(34.51±3.74)mg·L-1;Tmax were(1.00±0.00)h;t1/2β were(1.08±0.80),(0.89±0.14),(0.93±0.08)h;AUC0-t were(13.49±2.29),(28.91±4.92),(60.85±8.72) mg·L-1·h and CL were(11.09±1.58),(10.54±1.85),(9.98±1.39)L·h-1·kg-1,respectively.Urinary recoveries were 61.9%,62.1%,62.8% in 12 h after drug administration,respectively.Conclusion The plasma concentration-time curve of biapenem fits two compartment model,the pharmacokinetic parameters proportionate linearly to the dosages.All the subjects are well-tolerant.

  • 【文献出处】 中国临床药理学杂志 ,The Chinese Journal of Clinical Pharmacology , 编辑部邮箱 ,2012年03期
  • 【分类号】R96
  • 【被引频次】7
  • 【下载频次】251
节点文献中: 

本文链接的文献网络图示:

本文的引文网络